Surrozen (SRZN) Amortizatization of Intangibles (2020 - 2026)
Surrozen (SRZN) recorded quarterly Amortizatization of Intangibles of $450000.0 in Q1 2026, little changed quarter-over-quarter from $450000.0 in Q4 2025, and little changed on a YoY basis from $451000.0 in Q1 2025.
Surrozen (SRZN) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Surrozen's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $450000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.22% year-over-year to $450000.0; the TTM figure through Mar 2026 stood at $1.8 million (up 11.39% YoY), while the FY2025 annual figure was $1.8 million, up 18.33% from the prior year.
- Amortizatization of Intangibles was $450000.0 for Q1 2026 at Surrozen, roughly flat from $450000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.0 million in Q4 2022 to a low of -$241000.0 in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $374117.6 across 5 years, with a median of $367000.0 in 2022.
- Biggest YoY gain for Amortizatization of Intangibles was 825.71% in 2023; the steepest drop was 165.67% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.0 million in 2022, then slumped by 67.82% to $336000.0 in 2023, then jumped by 33.93% to $450000.0 in 2024, then changed by 0.0% to $450000.0 in 2025, then changed by 0.0% to $450000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $450000.0 (Q1 2026), $450000.0 (Q4 2025), and $450000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Surrozen | 235,841.47 | -106.67 Mn | - | 450,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Sep 30, 2025 | 450,000.00 |
| Sep 30, 2025 | 450,000.00 |
| Jun 30, 2025 | 450,000.00 |
| Jun 30, 2025 | 450,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 450,000.00 |
| Dec 31, 2024 | 450,000.00 |
| Sep 30, 2024 | 358,000.00 |
| Sep 30, 2024 | 358,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 357,000.00 |
| Mar 31, 2024 | 357,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Dec 31, 2023 | 336,000.00 |